Latest Breaking News On - University hospital gregorio maran - Page 1 : comparemela.com

A single-center study suggests that FMT and bezlotoxumab ― two recommended therapies for recurrent C difficile infections ― are not commonly used in Spain, which doesn t appear to align with US practice.

United statesPatricia munDavid johnsonAmerican college of gastroenterologyForum infectious diseasesUniversity hospital gregorio maranFerring pharmaceuticalsDrug administrationEastern virginia medical school in norfolkGeneral university hospital gregorio maranOpen forum infectiousEastern virginia medical schoolMedscape medicalAmerican collegeC diff infectionClostridium difficile infection